Pfizer is expected to announce its second-quarter results next month, and analysts predict a single-digit drop in the company ...

Analysts expect Johnson & Johnson to report an earnings per share (EPS) of $2.67. Johnson & Johnson bulls will hope to hear ...

Tech giants Alphabet and Tesla are set to report earnings this week. Investors should keep a close eye on economic reports coming giving this week. See more here.

Pfizer Inc. (NYSE:PFE) hasn’t performed well in recent years, with its stock declining more than 26% over the past decade.

Earnings season begins this week. With the tariff overhang and higher expectations for coming quarters, forward earnings ...

Expectations into Q2 have remained stable throughout the quarter. Last quarter, Netflix Inc. ( NFLX) guided to a stable ...

Many Wall Street analysts keep boosting their stock price target as the streaming giant's shares have gained around 40 ...

Pfizer PFE is one of the biggest players in the oncology space — a position it strengthened with the 2023 acquisition of Seagen. The deal added four antibody-drug conjugates (ADC) — Adcetris, Padcev, ...

The investment community will be closely monitoring the performance of Pfizer in its forthcoming earnings report. The company is scheduled to release its earnings on August 5, 2025.

Pfizer PFE is likely to encounter several headwinds in the next couple of years that can hurt its sales and profits, the first being declining sales of COVID products, Comirnaty and Paxlovid.